Chances are that investors would struggle to find a bigger (or buzzier) long-term growth opportunity at the moment than marijuana. Although black market cannabis sales continue to dominate, legal channel sales are soaring as new countries and U.S. states wave…
It’s been a great year for HEXO Corp. (NYSEMKT:HEXO) so far. The company reported tremendous revenue growth in its first full quarter of sales in the Canadian adult-use recreational marijuana market. It announced the acquisition of Newstrike Brands. And HEXO even received some love from…
Sure, earnings season may have passed for the lion’s share of brand-name companies, but that doesn’t mean earnings reports cease altogether. Next week, the biggest name in all of cannabis, Canopy Growth (NYSE:CGC), will be dishing on its performance in the fourth…
What happened Shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE) were shooting 18.9% higher as of 10:57 a.m. EDT on Tuesday. The big jump came after the biotech announced that it received a new patent for treating autism spectrum disorders using synthetic cannabidiol (CBD). So what…
Tilray shares surged more than 13% Monday in premarket trade after the Canadian pot company announced it struck a deal with its majority shareholder, a cannabis company backed by venture capitalist Peter Thiel, to sell the fund’s stake gradually over the…
Marijuana stocks vaulted into the limelight in 2018, and their performance in 2019 has generally been extremely strong. As more states have embraced cannabis by legalizing it for medical or recreational purposes, the opportunities for cannabis producers to capitalize on strong…
